Matches in Nanopublications for { ?s ?p "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1230944.RAr_UYeJB4vBGm61zZMVl1HzGje9iVtP7QOLioPLCH7GE130_assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230944.RAr_UYeJB4vBGm61zZMVl1HzGje9iVtP7QOLioPLCH7GE130_provenance.
- NP1230942.RAwIziWTmCJS3TLgVJbLE7b8x_U6MIor3AD0EglwOpWZQ130_assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230942.RAwIziWTmCJS3TLgVJbLE7b8x_U6MIor3AD0EglwOpWZQ130_provenance.
- NP1230943.RA9_xyxKY8g8cc3AkMen3qtDLhNnf4h-gXhOhX4PsLmp8130_assertion description "[Inactivating mutations in the GALT-II gene (B3GALT6) associated with Ehlers-Danlos syndrome cause proteoglycan maturation defects similar to FAM20B deletion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230943.RA9_xyxKY8g8cc3AkMen3qtDLhNnf4h-gXhOhX4PsLmp8130_provenance.